BIOMAT Database Logo BIOMAT Database Logo

[Current clinical aspects of primary hyperlipemia]. 1973

T Kovać, and B Vitić

UI MeSH Term Description Entries
D006949 Hyperlipidemias Conditions with excess LIPIDS in the blood. Hyperlipemia,Hyperlipidemia,Lipemia,Lipidemia,Hyperlipemias,Lipemias,Lipidemias
D009539 Nicotinic Acids 2-, 3-, or 4-Pyridinecarboxylic acids. Pyridine derivatives substituted with a carboxy group at the 2-, 3-, or 4-position. The 3-carboxy derivative (NIACIN) is active as a vitamin. Acids, Nicotinic
D009626 Terminology as Topic Works about the terms, expressions, designations, or symbols used in a particular science, discipline, or specialized subject area. Etymology,Nomenclature as Topic,Etymologies
D002792 Cholestyramine Resin A strongly basic anion exchange resin whose main constituent is polystyrene trimethylbenzylammonium Cl(-) anion. Cholestyramine,Colestyramine,Colestyramin,Cuemid,MK-135,Quantalan,Questran,Cholestyramine Resins,Cholestyramines,Colestyramines,Colestyramins,Cuemids,MK 135,MK135,Quantalans,Questrans,Resin, Cholestyramine,Resins, Cholestyramine
D002994 Clofibrate A fibric acid derivative used in the treatment of HYPERLIPOPROTEINEMIA TYPE III and severe HYPERTRIGLYCERIDEMIA. (From Martindale, The Extra Pharmacopoeia, 30th ed, p986) Athromidin,Atromid,Atromid S,Clofibric Acid, Ethyl Ester,Ethyl Chlorophenoxyisobutyrate,Miscleron,Miskleron,Chlorophenoxyisobutyrate, Ethyl
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D045930 Anabolic Agents These compounds stimulate anabolism and inhibit catabolism. They stimulate the development of muscle mass, strength, and power. Anabolic Effect,Anabolic Effects,Agents, Anabolic,Effect, Anabolic,Effects, Anabolic

Related Publications

T Kovać, and B Vitić
[Clinical and biological aspects of hyperlipemia].
April 1970, Medicina interna,
T Kovać, and B Vitić
[Risk factor hyperlipemia: clinical aspects and therapy].
September 1975, Die Medizinische Welt,
T Kovać, and B Vitić
[ON THE CLINICAL ASPECTS AND THERAPY OF HYPERLIPEMIA].
June 1964, Schweizerische medizinische Wochenschrift,
T Kovać, and B Vitić
["ESSENTIAL" HYPERLIPEMIA. ITS PRESENT CLINICAL AND BIOLOGICAL ASPECTS].
November 1963, La Presse medicale,
T Kovać, and B Vitić
[On the clinical aspects and therapy of essential hyperlipemia].
April 1963, Medizinische Klinik,
T Kovać, and B Vitić
[Clinical and pathophysiological aspects of diabetic and familial hyperlipemia].
September 1970, Iryo,
T Kovać, and B Vitić
Primary hyperlipemia.
November 1952, United States Armed Forces medical journal,
T Kovać, and B Vitić
[Current aspects of primary cancer of the liver. Its clinical and laboratory aspects].
February 1977, Revista espanola de las enfermedades del aparato digestivo,
T Kovać, and B Vitić
[Therapy of primary hyperlipemia].
October 1971, Deutsche medizinische Wochenschrift (1946),
T Kovać, and B Vitić
[Therapy of primary hyperlipemia].
May 1971, Deutsche medizinische Wochenschrift (1946),
Copied contents to your clipboard!